Loss of p53, rather than beta-catenin overexpression, induces survivin-mediated resistance to apoptosis in an esophageal cancer cell line
- PMID: 20236666
- DOI: 10.1016/j.jtcvs.2009.11.038
Loss of p53, rather than beta-catenin overexpression, induces survivin-mediated resistance to apoptosis in an esophageal cancer cell line
Abstract
Objective: Survivin, an important inhibitor of apoptosis, is overexpressed in esophageal cancer and negatively affects survival. The complex regulation of survivin transcription involves enhancement by beta-catenin and repression by p53. The purpose of this study is to test whether inhibition of beta-catenin or overexpression of p53 can decrease survivin expression and render esophageal cancer cells more susceptible to apoptosis.
Methods: Studies were performed in normal human esophageal epithelial cells and the human esophageal cancer cell line TE7. Levels of beta-catenin, survivin, and p53 were measured by Western blot. Apoptosis was induced after treatment with camptothecin and measured by release of caspase 3 and morphologic criteria. The roles of survivin and beta-catenin in preventing apoptosis were tested by their silencing with specific small interfering RNA molecules. The effect of p53 overexpression on survivin promoter activity was measured using a survivin promoter-luciferase reporter construct and by real-time polymerase chain reaction measurement of survivin mRNA levels.
Results: Both beta-catenin and survivin are overexpressed in TE7 cells, whereas p53 expression is negligible. TE7 cells demonstrate resistance to camptothecin-induced apoptosis (P < .01). This effect is significantly reduced by inhibition of survivin, but not of beta-catenin (P < .01). Overexpression of p53 in TE7 cells reduces survivin transcription and mRNA levels (P < .01), without reducing survivin protein levels.
Conclusion: Survivin plays a critical role in TE7 cell resistance to camptothecin-induced apoptosis. This effect is not dependent on beta-catenin expression. Overexpression of p53 decreases survivin transcription but does not decrease levels of survivin protein, suggesting posttranscriptional control of survivin expression.
2010 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.
Similar articles
-
Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.Cancer Invest. 2009 Jul;27(6):604-12. doi: 10.1080/07357900802337191. Cancer Invest. 2009. PMID: 19440933
-
Knockdown of survivin and upregulation of p53 gene expression by small interfering RNA induces apoptosis in human gastric carcinoma cell line SGC-823.Cancer Biother Radiopharm. 2008 Dec;23(6):727-34. doi: 10.1089/cbr.2008.0503. Cancer Biother Radiopharm. 2008. PMID: 19111044
-
Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression.Oncogene. 2005 May 19;24(22):3619-31. doi: 10.1038/sj.onc.1208433. Oncogene. 2005. PMID: 15782138
-
Cancer cells survive with survivin.Cancer Sci. 2008 Sep;99(9):1709-14. doi: 10.1111/j.1349-7006.2008.00870.x. Epub 2008 Jun 5. Cancer Sci. 2008. PMID: 18537980 Free PMC article. Review.
-
Investigations of survivin: the past, present and future.Front Biosci (Landmark Ed). 2011 Jan 1;16(3):952-61. doi: 10.2741/3728. Front Biosci (Landmark Ed). 2011. PMID: 21196211 Review.
Cited by
-
Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer.Oncotarget. 2016 Jul 12;7(28):44505-44521. doi: 10.18632/oncotarget.9887. Oncotarget. 2016. PMID: 27283986 Free PMC article.
-
Prognostic value and targeted inhibition of survivin expression in esophageal adenocarcinoma and cancer-adjacent squamous epithelium.PLoS One. 2013 Nov 4;8(11):e78343. doi: 10.1371/journal.pone.0078343. eCollection 2013. PLoS One. 2013. PMID: 24223792 Free PMC article.
-
Prognostic significance of survivin, β-catenin and p53 expression in urothelial carcinoma.Bosn J Basic Med Sci. 2015 Aug 19;15(4):7-14. doi: 10.17305/bjbms.2015.556. Bosn J Basic Med Sci. 2015. PMID: 26614845 Free PMC article.
-
Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1.Oncogene. 2016 Apr 21;35(16):2087-97. doi: 10.1038/onc.2015.271. Epub 2015 Aug 3. Oncogene. 2016. PMID: 26234674 Free PMC article.
-
Overexpression of cyclin B1 antagonizes chemotherapeutic-induced apoptosis through PTEN/Akt pathway in human esophageal squamous cell carcinoma cells.Cancer Biol Ther. 2013 Jan;14(1):45-55. doi: 10.4161/cbt.22627. Epub 2012 Oct 31. Cancer Biol Ther. 2013. PMID: 23114644 Free PMC article.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous